FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $298,000 | -9.7% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $330,000 | -36.0% | 13,300 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $516,000 | -42.0% | 13,300 | -12.5% | 0.00% | -25.0% |
| Q4 2021 | $889,000 | -1.3% | 15,200 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $901,000 | -31.7% | 15,200 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $1,319,000 | +19.4% | 15,200 | +13.4% | 0.01% | +16.7% |
| Q1 2021 | $1,105,000 | -9.3% | 13,400 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $1,218,000 | +127.2% | 13,400 | 0.0% | 0.01% | +75.0% |
| Q3 2020 | $536,000 | -25.6% | 13,400 | -36.2% | 0.00% | +33.3% |
| Q2 2020 | $720,000 | – | 21,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |